RALZAPASTOTUG
UNII J95TV367TU

Substance Identification & Data

This profile provides standardized clinical and technical data for Ralzapastotug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J95TV367TU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2581724-89-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J95TV367TU

CAS Registry Number

2581724-89-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RALZAPASTOTUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179552

National Cancer Institute reference terminology for clinical and research data.

INN ID

12340

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ralzapastotug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RALZAPASTOTUG

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HUMANIZED (1-451) (VH (HOMO SAPIENS IGHV4-4*10 (90.8%)-(IGHD) -IGHJ4*01 (100%), CDR-IMGT (9.7.14) (26-34.52-58.97-110)) (1-121) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS (450-451))(122-451)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01(86.5%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (230-230'': 233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT (T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMAN-MUS MUSCULUS MONOCLONAL AB308 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AB308 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)), HUMANIZED MONOCLONAL ANTIBODY

RALZAPASTOTUG [INN]

RALZAPASTOTUG [WHO-DD]